Cetera Investment Advisers
CVS icon

Cetera Investment Advisers’s CVS Health CVS Stock Holding History

Cetera Investment Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5M Buy
478,271
+17,961
+4% +$1.6M 0.05% 413
2026
Q1 		$33.1M Sell
460,310
-25,271
-5% -$1.95M 0.04% 497
2025
Q4 		$38.5M Sell
485,581
-29,657
-6% -$2.34M 0.04% 422
2025
Q3 		$38.8M Buy
515,238
+153,954
+43% +$10.6M 0.05% 403
2025
Q2 		$24.9M Buy
361,284
+16,321
+5% +$1.07M 0.04% 440
2025
Q1 		$23.4M Buy
344,963
+26,184
+8% +$1.57M 0.05% 416
2024
Q4 		$14.3M Buy
318,779
+6,524
+2% +$366K 0.03% 547
2024
Q3 		$19.6M Sell
312,255
-60,715
-16% -$3.54M 0.04% 422
2024
Q2 		$22M Sell
372,970
-34,874
-9% -$2.18M 0.05% 375
2024
Q1 		$32.5M Buy
407,844
+267,664
+191% +$20.4M 0.08% 264
2023
Q4 		$11.1M Buy
140,180
+7,198
+5% +$512K 0.09% 202
2023
Q3 		$9.28M Sell
132,982
-40,209
-23% -$2.85M 0.08% 236
2023
Q2 		$12M Sell
173,191
-11,109
-6% -$790K 0.1% 183
2023
Q1 		$13.7M Sell
184,300
-15,111
-8% -$1.27M 0.12% 152
2022
Q4 		$18.6M Buy
199,411
+59,204
+42% +$5.71M 0.17% 114
2022
Q3 		$13.4M Sell
140,207
-14,739
-10% -$1.46M 0.27% 82
2022
Q2 		$14.4M Buy
154,946
+14,420
+10% +$1.41M 0.23% 94
2022
Q1 		$14.2M Sell
140,526
-2,632
-2% -$276K 0.2% 106
2021
Q4 		$14.8M Sell
143,158
-4,390
-3% -$406K 0.21% 100
2021
Q3 		$12.5M Buy
147,548
+3,229
+2% +$270K 0.2% 111
2021
Q2 		$12M Buy
144,319
+9,946
+7% +$814K 0.19% 115
2021
Q1 		$10.1M Sell
134,373
-3,531
-3% -$257K 0.2% 107
2020
Q4 		$9.42M Buy
137,904
+106,653
+341% +$6.94M 0.19% 120
2020
Q3 		$1.82M Buy
31,251
+789
+3% +$49.1K 0.15% 164
2020
Q2 		$1.98M Buy
30,462
+778
+3% +$49K 0.18% 140
2020
Q1 		$1.76M Buy
29,684
+1,848
+7% +$123K 0.22% 126
2019
Q4 		$2.06M Buy
27,836
+82
+0.3% +$5.76K 0.21% 126
2019
Q3 		$1.75M Sell
27,754
-2,072
-7% -$123K 0.21% 124
2019
Q2 		$1.61M Buy
29,826
+13,056
+78% +$703K 0.21% 117
2019
Q1 		$898K Buy
16,770
+4,376
+35% +$270K 0.13% 182
2018
Q4 		$819K Buy
12,394
+2,269
+22% +$169K 0.13% 173
2018
Q3 		$802K Buy
10,125
+82
+0.8% +$5.86K 0.12% 191
2018
Q2 		$639K Buy
10,043
+470
+5% +$31K 0.11% 205
2018
Q1 		$589K Buy
9,573
+626
+7% +$44.9K 0.11% 210
2017
Q4 		$648K Buy
8,947
+765
+9% +$55.6K 0.12% 201
2017
Q3 		$662K Sell
8,182
-433
-5% -$34.3K 0.15% 186
2017
Q2 		$692K Buy
8,615
+309
+4% +$24.4K 0.17% 161
2017
Q1 		$656K Buy
8,306
+683
+9% +$54.5K 0.18% 148
2016
Q4 		$604K Sell
7,623
-358
-4% -$29K 0.2% 136
2016
Q3 		$709K Sell
7,981
-1,478
-16% -$140K 0.3% 95
2016
Q2 		$903K Buy
9,459
+1,931
+26% +$192K 0.35% 87
2016
Q1 		$779K Buy
7,528
+513
+7% +$49.9K 0.34% 86
2015
Q4 		$688K Buy
+7,015
New +$687K 0.32% 95

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cetera Investment Advisers's CVS Position: Q2 2026 in Review

Cetera Investment Advisers increased its CVS Health (CVS) stake by 3.9% in Q2 2026, buying an estimated $1.6M and bringing the position to 478,271 shares worth $49.5M. The position accounts for 0.05% of the portfolio, ranked #413.

Cetera Investment Advisers first reported a position in CVS in Q4 2015 and has held it in 43 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cetera Investment Advisers held 478,271 shares of CVS Health worth $49.5M as of Q2 2026.
  • Cetera Investment Advisers bought 17,961 CVS Health shares in Q2 2026, an estimated $1.6M.
  • CVS Health made up 0.05% of Cetera Investment Advisers's portfolio in Q2 2026, its #413 holding.
  • Cetera Investment Advisers first reported a position in CVS Health in Q4 2015 and has held it in 43 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.